Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sciclone Pharmaceuticals Inc (SCLN)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

1,891,328 $18,535 -13% 2.06%
2. 40,700 $399 0.53%
3.
GLG Partners

Noam Gottesman

363,188 $3,559 +273% 0.16%
4.
Sensato Capital Management

Ernest Chow And Jonathan Howe

61,867 $606 -86% 0.1%
5.
Navellier & Associates

Louis Navellier

30,439 $298 +10% 0.04%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaning Holdings Date Form 4
$6.00 25,040 Director 25,040 2014-08-15 Filing
$3.95 1,000 Officer, Director 50,036 2014-02-28 Filing
$4.15 1,000 Officer, Director 49,036 2013-11-30 Filing
$4.24 1,000 Officer, Director 48,036 2013-08-31 Filing
$3.68 1,000 Officer, Director 39,018 2013-02-28 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$9.36 6,298 Officer, Director 92,526 2017-05-24 Filing
$9.31 15,166 Officer, Director 92,526 2017-05-23 Filing
$9.44 18,536 Officer, Director 92,526 2017-05-22 Filing
$10.00 18,226 Officer, Director 92,526 2017-05-11 Filing
$10.00 164 Officer, Director 92,526 2017-05-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,663,281 $16,300 9.18%
2. 396,336 $3,884 0.38%
3. 30,439 $298 0.33%
4. 95,432 $935 0.3%
5. 240,013 $2,352 0.12%
News See All